Teikoku Pharma gets USFDA nod for non-alcohol docetaxel injection
Vaccines | News | By BioSpectrum Bureau | 0 Comment | 04 Jan, 2016
Singapore: Japan's Teikoku Pharma has recieved USFDA approval for Docetaxel injection, a non-alcohol formula for the tre...Read more
German firm proceeds on ebola vaccine trial
Vaccines | News | By BioSpectrum Bureau | 0 Comment | 04 Jun, 2015
Singapore: Germany based complex biologics development and manufacturing specialist, ProBioGen, has proceeded on the cli...Read more
Merck's Ebola vaccine found promising in clinical trials
Vaccines | News | By BioSpectrum Bureau | 0 Comment | 03 Aug, 2015
Singapore: In a recent interim study published in the Lancet medical journal, Merck's Ebola vaccine was found to be "hig...Read more
Teva recalls Adrucil injection for potential foriegn particle presence
Vaccines | Regulatory | By BioSpectrum Bureau | 2 Comment | 28 Jul, 2015
Singapore: Teva Parenteral Medicines has recalled six lots of Adrucil (fluorouracil injection) due to the potential pres...Read more
Drug resistance keeps malaria threat alive in India
Vaccines | Analysis | By Rahul Koul Koul | 2 Comment | 02 Jul, 2012
The current anti-malarial market in India is approximately $80 million (Rs 450 crore) with an annual growth rate of 17 p...Read more
New vaccine against Hepatatis B developed by Cuba
Vaccines | News | By BioSpectrum Bureau | 0 Comment | 17 Aug, 2015
Singapore: Researchers from Cuba have developed a new vaccine for treatment of chronic hepatitis B. The vaccine HeberNas...Read more
Malaria vaccine, Mosquirix, gets European nod
Vaccines | News | By BioSpectrum Bureau | 0 Comment | 24 Jul, 2015
Singapore: GlaxoSmithKline has received a positive opinion for its Malaria vaccine candidate from the Committee for Medi...Read more
Novavax's Ebola vaccine shows promise in human trial
Vaccines | News | By BioSpectrum Bureau | 0 Comment | 22 Jul, 2015
Singapore: US-based Novavax recently announced that its experimental candidate vaccine for Ebola showed promise in early...Read more
No more needles, no more pain!
Vaccines | News | By BioSpectrum Bureau | 0 Comment | 21 Jul, 2015
Singapore: Vaccination will no longer be a painful process as researchers from Japan's Osaka University have developed a...Read more
Shanghai BravoBio wins BioSpectrum award for role in China vaccine industry
Vaccines | Influencers | By BioSpectrum Bureau | 4 Comment | 15 Mar, 2013
Chinese vaccine development companies are raising the bar to meet international standards. However, access to foreign ma...Read more
WHO and World Food Program join forces to reach zero Ebola cases
Vaccines | News | By BioSpectrum Bureau | 0 Comment | 12 Mar, 2015
Singapore: WHO and United Nations World Food Program (WFP) have come together to build logistics strength for Ebola-affe...Read more
FDA nod for Sanofi quadrivalent flu vaccine
Vaccines | Regulatory | By BioSpectrum Bureau | 2 Comment | 11 Jun, 2013
Singapore: The US FDA has approved Sanofi Pasteur supplemental biologics license application (sBLA) for its four-strain ...Read more
Vaccine for AIDS in ten years: Bill Gates
Vaccines | News | By BioSpectrum Bureau | 0 Comment | 02 Jul, 2015
Singapore: With no cure or vaccine available for AIDS, that is spreading across the globe like a wide epidemic, billiona...Read more
AIDS 2014: Slash in fund jolts HIV research
Vaccines | News | By BioSpectrum Bureau | 0 Comment | 21 Jul, 2014
Singapore: Investment in HIV prevention research has declined posing a challenge to the pipeline of HIV prevention produ...Read more
Novartis completes divestiture of influenza vaccines business
Vaccines | News | By BioSpectrum Bureau | 0 Comment | 18 Aug, 2015
Singapore: Novartis has announced that it has completed the divestiture of its influenza vaccine unit to CSL Limited. Th...Read more
J&J's HIV vaccine to begin human trials
Vaccines | News | By BioSpectrum Bureau | 0 Comment | 10 Jul, 2015
Singapore: Bringing new hope to millions of people worldwide, the experimental HIV vaccine developed by Johnson & Jo...Read more
Agilent, A*Star, French univ sign biologics MoU
Vaccines | News | By BioSpectrum Bureau | 0 Comment | 27 May, 2013
Singapore: Agilent Technologies, Glyco-MEV laboratory at the University of Rouen, France, and Bioprocessing Technology I...Read more
Stanford Univ reverse vaccine to treat diabetes
Vaccines | News | By BioSpectrum Bureau | 0 Comment | 28 Jun, 2013
Singapore: Scientists at Stanford University, US, and Leiden University Medical Center in the Netherlands, have tested a...Read more